Home  /  Resource Library  /  Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

ASH 2020: Retrospective study examined the efficacy of high dose methotrexate for prevention of central nervous system relapse in patients with diffuse large b-cell lymphoma.